Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Beat: Neoadjuvant Bevacizumab in Rectal Cancer
NCT01554059Phase 2Completed
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal adenocarcinoma, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started Mar 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT01554059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554059.